Caricamento...
Treg cells, cancer vaccines: timing is everything
In the current issue of Blood, Litzinger and colleagues demonstrate the critical role of proper timing of the denileukin diftitox (ONTAK) treatment for its ability to boost the immunologic activity of cancer vaccines.
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society of Hematology
2007
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2200914/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-07-102921 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|